News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020
News Daily News TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths Michael O'Riordan September 30, 2020
News Daily News As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes Todd Neale September 23, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News Too Many HF Trial Results Underreported or Never Published L.A. McKeown June 23, 2020
News Features Cardiology After COVID-19: Physicians Predict Lasting Change Yael L. Maxwell May 20, 2020
News Conference News ACC 2020 New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals Michael O'Riordan April 06, 2020
News Conference News ACC 2020 Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry Michael O'Riordan March 19, 2020
News Opinion Off Script COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose? Asif Qasim, MB BChir, PhD March 06, 2020
News Daily News Gender Gaps Persist in CV Research, Editorships, and Training Yael L. Maxwell February 20, 2020
News Daily News Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA Michael O'Riordan January 21, 2020